AgilVax's Series A - III Round

AgilVax raised a round of funding on August 28, 2019.

Agilvax is a biotechnology company employing a vaccine discovery platform to develop safe and efficacious vaccines for infectious diseases and chronic conditions. The platform is based on virus-like p…

Articles about AgilVax's Series A - III Round: